RecruitingNot ApplicableNCT07704905

A Study to Investigate the Efficacy of an Experimental Dentifrice Containing Stannous Fluoride in Improving Gingival Health

An 8-Week Randomized, Controlled, Examiner-Blind, Clinical Study Investigating the Efficacy of an Experimental Dentifrice Containing Stannous Fluoride in Improving Gingival Health


Sponsor

HALEON

Enrollment

110 participants

Start Date

Jul 13, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study will be to evaluate the ability of using an experimental dentifrice containing 0.454 percent (%) weight for weight (w/w) Stannous Fluoride (SnF2) to reduce gingivitis and plaque accumulation, compared with a regular fluoride toothpaste (negative control) in participants with mild to moderate gingivitis.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Reference Dentifrice (Colgate Cavity Protection Dentifrice) and a drug called Test Dentifrice for people with dental plaque and gingivitis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTest Dentifrice

Experimental dentifrice containing 0.454% w/w SnF2.

DRUGReference Dentifrice (Colgate Cavity Protection Dentifrice)

A marketed regular fluoride dentifrice.


Locations(1)

Salus Research Inc

Fort Wayne, Indiana, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07704905


Related Trials